i
An Illustration of the Potential Health and Economic Benefits of Combating Antibiotic-Resistant Gonorrhea
-
April 2018
-
-
Source: Sex Transm Dis. 45(4):250-253
Details:
-
Alternative Title:Sex Transm Dis
-
Personal Author:
-
Description:Preventing the emergence of ceftriaxone-resistant Neisseria gonorrhoeae can potentially avert hundreds of millions of dollars in direct medical costs of gonorrhea and gonorrhea-attributable HIV infections. In the illustrative scenario we examined, emerging ceftriaxone resistance could lead to 1.2 million additional N. gonorrhoeae infections within 10 years, costing $378.2 million.
-
Subjects:
-
Source:
-
Pubmed ID:29465709
-
Pubmed Central ID:PMC6724164
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: